QLGN logo

QLGN
Qualigen Therapeutics Inc

37,009
Mkt Cap
$14.86M
Volume
211,934.00
52W High
$8.81
52W Low
$1.61
PE Ratio
-0.30
QLGN Fundamentals
Price
$2.63
Prev Close
$2.88
Open
$2.90
50D MA
$3.60
Beta
0.48
Avg. Volume
3.04M
EPS (Annual)
-$17.28
P/B
3.29
Loading...
Loading...
Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company was founded on March 29, 2004 and is headquartered in Carlsbad, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Market Cap of AIxCrypto Holdings Inc.?
What is the 52-week high for AIxCrypto Holdings Inc.?
What is the 52-week low for AIxCrypto Holdings Inc.?
What is AIxCrypto Holdings Inc. stock price today?
What was AIxCrypto Holdings Inc. stock price yesterday?
What is the PE ratio of AIxCrypto Holdings Inc.?
What is the Price-to-Book ratio of AIxCrypto Holdings Inc.?
What is the 50-day moving average of AIxCrypto Holdings Inc.?

Latest QLGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.